JPRN-jRCT2080220304
Unknown
Phase 3
A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure
ovartis Pharma K.K.0 sites356 target enrollmentOctober 3, 2006
ConditionsHypertension
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- ovartis Pharma K.K.
- Enrollment
- 356
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria
- •\- Patients with at least 65 years\-old
- •\- Patients with essential hypertension
- •Exclusion criteria
- •\- Severe hypertension
- •\- History or evidence of a secondary form of hypertension
- •\- History of Hypertensive encephalopathy or cerebrovascular accident.
- •Other protocol\-defined inclusion/exclusion criteria also apply
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Clinical Study on Diabetes supplement in participants with diabetes.Health Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2024/04/065001Emil Pharmaceutical Industries Private Limited,
Not yet recruiting
Phase 2
Effect of Boozidaan(Pyrethrum Indicum)on Niqris Muzmin(chronic gout)Health Condition 1: M1A9- Chronic gout, unspecifiedCTRI/2021/03/032150Central council for Research in Unani Medicine New Delhi
Completed
Not Applicable
Clinical safety and efficacy Study â??ROMANTAQUE LOTIONâ??.CTRI/2015/02/005534Mrs Mrinmayee Bhushan Kondhalkar30
Not yet recruiting
Phase 2
Clinical study of Softovac Liquifibre in constipatioHealth Condition 1: K590- ConstipationCTRI/2023/03/051094upin Limited
Completed
Phase 2
A Clinical study of Ostofix Tablet in subjects suffering from Osteoarthritis of Knee(s)CTRI/2014/02/004373ARJUN HEALTHCARE36